| abstract |
The present invention belongs to the field of medicinal chemistry, and specifically relates to a class of uricosuric URAT1 inhibitors, which are compounds represented by the structure of formula (I) or pharmaceutically acceptable salts thereof. hURAT1 has a very good inhibitory effect on transporting uric acid in the transfected cells, indicating that this type of compound has a good application prospect in the treatment of hyperuricemia or gout. |